Faith Osier — SPARQNOW

At-a-Glance

Co-Director, School of Convergence Science for Health & Technology at Imperial College London.
Chair of Malaria Immunology & Vaccinology.
Leads two core teams of over 25 scientists across KEMRI–Wellcome, Kenya and Heidelberg University Hospital, Germany, focusing on malaria vaccine development.
Provides executive oversight for teams comprising ~800 individuals at KEMRI-Wellcome Trust Research Programme (KWTRP), managing five-year budgets exceeding $120M.
President-elect of the International Union of Immunological Societies, representing over 60,000 members globally.
Designed the KILchip ©, an innovative custom protein microarray, the first of its kind in Africa.
Serves on Boards and Expert Committees at organizations including the WHO, Wellcome, UKRI, MVI-PATH, and BactiVac.

Biography

Prof. Faith Osier serves as Co-Director of the School of Convergence Science for Health & Technology at Imperial College London and holds the position of Chair of Malaria Immunology & Vaccinology. Her primary vision is to eradicate malaria, leading two core teams of over 25 scientists across KEMRI–Wellcome, Kenya, and Heidelberg University Hospital, Germany.